ProQR Therapeutics N.V.
(PRQR) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
2.62
0.00%
After-hours Jan 06, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Cash & Equivalents | 118.92M | 94.78M | 187.52M | 75.84M | 111.95M | 105.58M | 48.10M | 59.20M | 94.86M | 112.74M | 4.13M | 249.00K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 621.00K | 629.00K | 107.00K | 429.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 1.27M | 57.24M | n/a | 421.00K | n/a | 1.24M | n/a | 1.56M | 1.50M | 426.00K | 130.00K | 47.00K |
Inventory | n/a | 6.87K | 266.45K | 379.00K | 340.00K | 899.00K | 73.00K | 1.17M | 547.00K | 327.00K | n/a | n/a |
Other Current Assets | 793.00K | 2.45M | 3.14M | -800.00K | 1.53M | -2.14M | 1.99M | 1.25M | 1.40M | -753.00K | 2.00K | 3.00K |
Total Current Assets | 120.99M | 154.46M | 191.48M | 80.02M | 114.67M | 108.37M | 50.56M | 62.02M | 97.77M | 113.90M | 4.26M | 299.00K |
Property-Plant & Equipment | 16.90M | 16.24M | 17.47M | 18.60M | 2.44M | 1.86M | 2.50M | 3.44M | 2.20M | 1.19M | 204.00K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | 39.00K | 90.00K | 141.00K | 163.00K | 39.00K | 39.00K |
Total Long-Term Assets | 16.90M | 16.86M | 18.10M | 18.71M | 2.87M | 1.86M | 2.54M | 3.53M | 2.34M | 1.35M | 243.00K | 39.00K |
Total Assets | 137.88M | 171.32M | 209.58M | 98.73M | 117.53M | 110.23M | 53.10M | 65.54M | 100.11M | 115.25M | 4.50M | 338.00K |
Account Payables | 1.54M | 392.00K | 191.00K | 221.00K | 445.00K | 135.00K | 546.00K | 328.00K | 885.00K | 1.25M | 745.00K | 95.00K |
Deferred Revenue | 20.57M | 5.76M | 5.12M | 700.00K | 711.00K | 545.00K | 347.00K | n/a | 144.00K | 468.00K | 46.00K | n/a |
Short-Term Debt | 1.61M | 3.89M | 6.30M | 2.40M | 851.00K | n/a | 1.96M | n/a | 15.00K | 34.00K | 2.55M | n/a |
Other Current Liabilities | 8.82M | 10.07M | 14.76M | 6.96M | 8.81M | 7.48M | 4.62M | 6.07M | 4.21M | 1.39M | 279.00K | 45.00K |
Total Current Liabilities | 34.20M | 21.11M | 27.60M | 10.30M | 10.99M | 8.16M | 8.49M | 6.71M | 5.49M | 3.01M | 3.60M | 143.00K |
Long-Term Debt | 18.12M | 18.08M | 54.07M | 31.88M | 12.71M | 9.39M | 5.28M | 5.70M | 4.82M | 2.83M | 991.00K | 96.00K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 62.29M | 85.10M | 68.75M | 31.88M | 12.71M | 9.39M | 5.28M | 5.70M | 4.82M | 2.83M | 991.00K | 96.00K |
Total Liabilities | 96.49M | 106.21M | 96.35M | 42.18M | 23.70M | 17.55M | 13.78M | 12.41M | 10.31M | 5.84M | 4.59M | 239.00K |
Total Debt | 19.73M | 21.97M | 60.37M | 34.28M | 13.56M | 9.39M | 7.24M | 5.70M | 4.84M | 2.86M | 3.54M | 96.00K |
Common Stock | 3.37M | 3.37M | 3.00M | 2.17M | 2.16M | 1.73M | 1.46M | 934.00K | 934.00K | 934.00K | 59.00K | 33.00K |
Retained Earnings | -400.85M | -380.68M | -317.77M | -257.75M | -211.75M | -155.44M | -119.37M | -75.73M | -36.63M | -15.80M | -3.67M | -418.00K |
Comprehensive Income | 25.98M | 30.26M | 30.30M | -189.00K | 151.00K | 108.00K | 136.00K | -15.00K | 1K | 687.00K | 41.00K | n/a |
Shareholders Equity | 41.39M | 65.50M | 113.83M | 57.09M | 94.33M | 92.92M | 39.36M | 53.14M | 89.80M | 109.40M | -89.00K | 99.00K |
Total Investments | -98.05K | 621.00K | 629.00K | 107.00K | 429.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |